Medición De La Calidad De Vida Por Medio Del “Dermatology Life Quality Index” En Pacientes Con Psoriasis: Una Revisión Sistemática

Abstract

Objective: To evaluate quality of life related to health in patients with psoriasis, through the Dermatology Life Quality Index (DLQI). Methods: A systematic review about quality of life related to health in patients with psoriasis and has been used the DLQI. Search included studies published between 1994 and 2012. Studies that evaluated quality of life related to drug treatments were excluded. Results: Eight studies met the inclusion and exclusion criteria. There was a loss of quality of life in patients with psoriasis. DLQI was reported in two studies with 6.4 and 10.8 averages; disease length ranged between 17.6 and 28.9 years. Conclusion: Psoriasis affects quality of life of patients with the disease, from mild to moderate forms, and this deterioration is greater than those found in patients with acne or vitiligo.